Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald E Hricik, MD
University Hospitals of Cleveland, Division of Nephrology & Hypertension
Study Chair - Peter S. Heeger, MD
Icahn School of Medicine at Mount Sinai, Recanati Miller Transplant Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Manitoba
Winnipeg, Manitoba, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California, Los Angeles
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Yale University
New Haven, Connecticut, United States
- Emory University
Atlanta, Georgia, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Maryland
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
- Mount Sinai Medical Center
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospitals of Cleveland
Cleveland, Ohio, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Nov 2015
- Primary completion
- 23 Jul 2021
- Completion
- 23 Jul 2021
- Last update posted
- 16 Aug 2022
- Registered enrollment
- 290
- Registry id
- NCT02495077
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.